Combining PARP inhibitors, recently approved for the treatment of BRCA-mutant ovarian cancer, with another small molecule inhibitor was effective to treat ovarian cancers without BRCA1 and BRCA2 gene mutations, research indicates.
from Top Health News – ScienceDaily http://bit.ly/2yZ5y37
from Tumblr http://bit.ly/2D70I7e
No comments:
Post a Comment